Literature DB >> 9495661

Does lowering the blood pressure improve the mood? Quality-of-life results from the Hypertension Optimal Treatment (HOT) study.

I Wiklund1, K Halling, T Rydén-Bergsten, A Fletcher.   

Abstract

Nine-hundred-and-twenty-two hypertensive patients were included in a substudy to the Hypertension Optimal Treatment study, which aimed to investigate the impact on quality of life of lowering the pressure and of intensified therapy. Seven-hundred-and-eighty-one patients completed both baseline and follow-up questionnaires (intention-to-treat population), while 610 patients were included in a per protocol analysis. Patients were randomized to three diastolic BP levels (DBPs), i.e. < or =90 mmHg, < or =85 mmHg and < or =80 mmHg. Two self-administered validated questionnaires, the Psychological General Well-Being index and the Subjective Symptoms Assessment Profile (SSA-P) were completed at baseline and after 6 months. The lower the DBP achieved, the greater the improvement in well-being (p < 0.05). The increase in well-being from baseline to 6 months was significant in target groups < or =80 mmHg (p < 0.01) and < or =85 mmHg (p < 0.05). The SSA-P domains, cardiac symptoms and dizziness improved in all groups but the sex life score deteriorated in the < or =80 and < or =85 mmHg groups in male patients. In all target groups, headaches were reduced (p < 0.001), while swollen ankles (p < 0.001) and dry cough in the < or =80 mmHg group (p < 0.001) increased. Although more intensive antihypertensive therapy is associated with a slight increase in subjective symptoms, it is nonetheless still associated with improvements in patients' well-being.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9495661     DOI: 10.3109/08037059709062095

Source DB:  PubMed          Journal:  Blood Press        ISSN: 0803-7051            Impact factor:   2.835


  31 in total

1.  The effect of lowering blood pressure on quality of life.

Authors:  C J Bulpitt
Journal:  Curr Hypertens Rep       Date:  2000-12       Impact factor: 5.369

2.  Current trials.

Authors:  F H Messerli
Journal:  Curr Hypertens Rep       Date:  1999-06       Impact factor: 5.369

Review 3.  [Arterial hypertension and dementia].

Authors:  R Scheid; H Voigt
Journal:  Nervenarzt       Date:  2005-02       Impact factor: 1.214

4.  Effects of music on systolic blood pressure, diastolic blood pressure, and heart rate: a meta-analysis.

Authors:  Rohit S Loomba; Rohit Arora; Parinda H Shah; Suraj Chandrasekar; Janos Molnar
Journal:  Indian Heart J       Date:  2012 May-Jun

5.  2010 Canadian Hypertension Education Program recommendations: An annual update.

Authors:  Norm Campbell; Margaret Moy Lum Kwong
Journal:  Can Fam Physician       Date:  2010-07       Impact factor: 3.275

6.  2009 Canadian Hypertension Education Program recommendations: an annual update.

Authors: 
Journal:  Can Fam Physician       Date:  2009-07       Impact factor: 3.275

7.  The Secondary Prevention of Small Subcortical Strokes (SPS3) study.

Authors:  Oscar R Benavente; Carole L White; Lesly Pearce; Pablo Pergola; Ana Roldan; Marie-France Benavente; Christopher Coffey; Leslie A McClure; Jeff M Szychowski; Robin Conwit; Patricia A Heberling; George Howard; Carlos Bazan; Gabriela Vidal-Pergola; Robert Talbert; Robert G Hart
Journal:  Int J Stroke       Date:  2011-01-26       Impact factor: 5.266

Review 8.  Health-related quality-of-life measurement in hypertension. A review of randomised controlled drug trials.

Authors:  I Côté; J P Grégoire; J Moisan
Journal:  Pharmacoeconomics       Date:  2000-11       Impact factor: 4.981

Review 9.  Health-related quality of life outcomes in chronic kidney disease.

Authors:  Ritu K Soni; Steven D Weisbord; Mark L Unruh
Journal:  Curr Opin Nephrol Hypertens       Date:  2010-03       Impact factor: 2.894

10.  Low blood pressure and antihypertensive treatment are independently associated with physical and mental health status in patients with arterial disease: the SMART study.

Authors:  M Muller; H M Jochemsen; F L J Visseren; A M Grool; L J Launer; Y van der Graaf; M I Geerlings
Journal:  J Intern Med       Date:  2013-04-11       Impact factor: 8.989

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.